Your Health, We Care
WhatsApp:
Dosage form:tablets
Specs:200mg*60 tablets
Indate:24 months
Capmatinib is an antineoplastic agent (cancer medication). It works by interfering with the growth o···【more】
Recommended：1862026-09-01
Capmatinib is indicated for the treatment of metastatic (spread) non-small cell lung cancer (NSCLC) ···【more】
Recommended：2072026-09-01
Capmatinib is a targeted therapy for non-small cell lung cancer with MET exon 14 skipping mutations. For patients using this drug, the most crucial concerns are undoubtedly the pur···【more】
Article source：Lucius LaosRelease date：2026-03-13Recommended：167
Capmatinib (Tabrecta) is a highly selective MET receptor tyrosine kinase inhibitor that specifically inhibits MET receptors and the phosphorylation process of MET-mediated downstre···【more】
Article source：Lucius LaosRelease date：2026-03-13Recommended：229
Capmatinib is an antineoplastic agent (cancer medication). It works by interfering with the growth of cancer cells, ultimately leading to their destruction.2026 Latest Price of Cap···【more】
Article source：Lucius LaosRelease date：2026-01-09Recommended：186
Capmatinib is indicated for the treatment of metastatic (spread) non-small cell lung cancer (NSCLC) in patients whose tumors harbor abnormal mesenchymal-epithelial transition facto···【more】
Article source：Lucius LaosRelease date：2026-01-09Recommended：207
Capmatinib is a targeted therapy for patients with non-small cell lung cancer with specific gene mutations, with significant efficacy and a relatively good safety profile.What is t···【more】
Article source：Lucius LaosRelease date：2024-08-06Recommended：415
Capmatinib is an oral drug manufactured by Novartis Pharmaceutical. It is a tyrosine kinase inhibitor that specifically targets the c-Met receptor. Capmatinib has shown durable eff···【more】
Article source：Lucius LaosRelease date：2024-08-06Recommended：355
Capmatinib inhibits the growth of cancer cells caused by specific genetic variants, i.e., MET exon 14 skipping or MET amplification. These genetic variants are common in tumors suc···【more】
Article source：Lucius LaosRelease date：2024-08-06Recommended：420
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
